Calculation of your study is finished. Please find your results below.

A study for a 69 year old woman who takes Crestor, Fosamax, Levothyroxine Sodium (an AI-powered real world drug study)

Summary:

9,848 females aged 69 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 69 year old female patient who has High Cholesterol, Bone Loss, Low Thyroid. The study is created by eHealthMe based on reports from sources including the FDA.


On Sep, 08, 2025

9,848 females aged 69 (±5) who take Crestor, Fosamax, Levothyroxine Sodium and have adverse effects are studied.


Number of reports submitted per year:

Crestor, Fosamax, Levothyroxine Sodium for a 69-year old woman.

Information of the patient in this study:

  • Age: 69
  • Gender: female
  • Conditions: High Cholesterol, Bone Loss, Low Thyroid
  • Drugs taken:
    • Crestor (rosuvastatin calcium)
    • Fosamax (alendronate sodium)
    • Levothyroxine Sodium (levothyroxine sodium)

Common drug interactions *:

  1. Fatigue (feeling of tiredness): 963 people, 9.78%
  2. Nausea (feeling of having an urge to vomit): 959 people, 9.74%
  3. Joint Pain : 870 people, 8.83%
  4. Fall : 823 people, 8.36%
  5. Weakness : 760 people, 7.72%
  6. Diarrhea : 759 people, 7.71%
  7. Pain : 700 people, 7.11%
  8. Headache (pain in head): 697 people, 7.08%
  9. Pain In Extremity : 694 people, 7.05%
  10. Dizziness : 681 people, 6.92%
  11. Dyspnea (difficult or laboured breathing): 672 people, 6.82%
  12. High Blood Pressure : 653 people, 6.63%
  13. Drug Ineffective : 603 people, 6.12%
  14. Rashes (redness): 589 people, 5.98%
  15. Urinary Tract Infection : 578 people, 5.87%
  16. Back Pain : 555 people, 5.64%
  17. Nausea And Vomiting : 512 people, 5.20%
  18. Cough : 500 people, 5.08%
  19. Malaise (a feeling of general discomfort or uneasiness): 500 people, 5.08%
  20. Pneumonia : 499 people, 5.07%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. High Blood Pressure : 1,146 people, 11.64%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1,141 people, 11.59%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 580 people, 5.89%
  4. Pain : 525 people, 5.33%
  5. Diabetes : 455 people, 4.62%
  6. Depression : 429 people, 4.36%
  7. Stress And Anxiety : 308 people, 3.13%
  8. Asthma : 280 people, 2.84%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 270 people, 2.74%
  10. Type 2 Diabetes : 257 people, 2.61%
  11. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 254 people, 2.58%
  12. Hyperlipidaemia (presence of excess lipids in the blood): 246 people, 2.50%
  13. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 237 people, 2.41%
  14. Cardiac Disorder : 231 people, 2.35%
  15. Psoriasis (immune-mediated disease that affects the skin): 218 people, 2.21%
  16. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 193 people, 1.96%
  17. Hypersensitivity : 178 people, 1.81%
  18. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 175 people, 1.78%
  19. Multiple Myeloma (cancer of the plasma cells): 174 people, 1.77%
  20. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 173 people, 1.76%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Aspirin (1,150 people, 11.68%)
  2. Metformin (814 people, 8.27%)
  3. Nexium (765 people, 7.77%)
  4. Calcium (697 people, 7.08%)
  5. Vitamin D3 (694 people, 7.05%)
  6. Lasix (642 people, 6.52%)
  7. Amlodipine (611 people, 6.20%)
  8. Prednisone (610 people, 6.19%)
  9. Lipitor (547 people, 5.55%)
  10. Pantoprazole (540 people, 5.48%)
  11. Vitamin D (535 people, 5.43%)
  12. Methotrexate (520 people, 5.28%)
  13. Lyrica (517 people, 5.25%)
  14. Humira (514 people, 5.22%)
  15. Tylenol (511 people, 5.19%)
  16. Folic Acid (510 people, 5.18%)
  17. Omeprazole (482 people, 4.89%)
  18. Plavix (468 people, 4.75%)
  19. Singulair (457 people, 4.64%)
  20. Cymbalta (446 people, 4.53%)

Drug effectiveness *:

Crestor:
  • not at all: 0 %
  • somewhat: 11.11 %
  • moderate: 11.11 %
  • high: 22.22 %
  • very high: 55.56 %
Fosamax:
  • not at all: 0 %
  • somewhat: 66.67 %
  • moderate: 33.33 %
  • high: 0 %
  • very high: 0 %
Levothyroxine Sodium:
  • not at all: 0 %
  • somewhat: 15.38 %
  • moderate: 7.69 %
  • high: 46.15 %
  • very high: 30.77 %

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug interactions:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.